Cite

    Ponnusamy, S. et al. (2017). An estrogen receptor β-selective agonist inhibits non-alcoholic steatohepatitis in preclinical models by regulating bile acid and xenobiotic receptors. Experimental biology and medicine. 242 (6), pp. 606-616. [Online].